BioNTech SE is a biotech company that develops immunotherapies for cancer and other infectious diseases. The company has multiple product candidates in various phases of clinical trials to treat different types of cancers, including melanoma, prostate cancer, and breast cancer. BioNTech SE is also developing a prophylactic vaccine for COVID-19 and has collaborations with several pharmaceutical companies.